Market Value1,351,655,000
Total Holdings74
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NNOX / Nano-X Imaging Ltd.
OMCL / Omnicell, Inc.
KRTX / Karuna Therapeutics, Inc.
KRMD / KORU Medical Systems, Inc.
NVST / Envista Holdings Corporation
BIO / Bio-Rad Laboratories, Inc.
ZYME / Zymeworks Inc.
APTO / Aptose Biosciences Inc.
BAX / Baxter International Inc.
US33830X1046 / Five Prime Therapeutics Inc
ELV / Elevance Health, Inc.
GKOS / Glaukos Corporation
DYN / Dyne Therapeutics, Inc.
DYNT / Dynatronics Corporation
XENT / Intersect ENT Inc
IBB / iShares Trust - iShares Biotechnology ETF
PSCH / Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Health Care ETF
VAPO / Vapotherm, Inc.
/ Oxford Immunotec Global PLC
JYNT / The Joint Corp.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
LHCG / LHC Group Inc
NVS / Novartis AG - Depositary Receipt (Common Stock)
HGEN / Humanigen, Inc.
/ Immunomedics, Inc.
US62857M1053 / MyoKardia, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
UNH / UnitedHealth Group Incorporated
AMGN / Amgen Inc.
BTAI / BioXcel Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
CDXS / Codexis, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
HRC / Hill-Rom Holdings Inc
NUVA / Nuvasive Inc
SNY / Sanofi - Depositary Receipt (Common Stock)
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
MODN / Model N, Inc.
MRK / Merck & Co., Inc.
IONS / Ionis Pharmaceuticals, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
JAZZ / Jazz Pharmaceuticals plc
MEIP / MEI Pharma, Inc.
CDNA / CareDx, Inc
XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund
ARNA / Arena Pharmaceuticals Inc
YMAB / Y-mAbs Therapeutics, Inc.
A / Agilent Technologies, Inc.
STRO / Sutro Biopharma, Inc.
TNDM / Tandem Diabetes Care, Inc.
QDEL / QuidelOrtho Corporation
CVS / CVS Health Corporation
SPNE / SeaSpine Holdings Corp
IHI / iShares Trust - iShares U.S. Medical Devices ETF
PRTA / Prothena Corporation plc
KRYS / Krystal Biotech, Inc.
TPTX / Turning Point Therapeutics Inc
HALO / Halozyme Therapeutics, Inc.
PFE / Pfizer Inc.
PRGO / Perrigo Company plc
ICUI / ICU Medical, Inc.
BDX / Becton, Dickinson and Company
HOLX / Hologic, Inc.
SYNH / Syneos Health Inc - Class A
KIDS / OrthoPediatrics Corp.
ATEC / Alphatec Holdings, Inc.
CI / The Cigna Group
GILD / Gilead Sciences, Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
JNJ / Johnson & Johnson
INSM / Insmed Incorporated
MASS / 908 Devices Inc.
HCAT / Health Catalyst, Inc.
ABBV / AbbVie Inc.
SLP / Simulations Plus, Inc.
OPRX / OptimizeRx Corporation
RARE / Ultragenyx Pharmaceutical Inc.
ATRC / AtriCure, Inc.
AXGN / Axogen, Inc.
SIBN / SI-BONE, Inc.
NEO / NeoGenomics, Inc.